Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 06 2021
01 06 2021
Historique:
entrez:
10
6
2021
pubmed:
11
6
2021
medline:
22
6
2021
Statut:
epublish
Résumé
Multisystem inflammatory syndrome in children (MIS-C) is associated with recent or current SARS-CoV-2 infection. Information on MIS-C incidence is limited. To estimate population-based MIS-C incidence per 1 000 000 person-months and to estimate MIS-C incidence per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. This cohort study used enhanced surveillance data to identify persons with MIS-C during April to June 2020, in 7 jurisdictions reporting to both the Centers for Disease Control and Prevention national surveillance and to Overcoming COVID-19, a multicenter MIS-C study. Denominators for population-based estimates were derived from census estimates; denominators for incidence per 1 000 000 SARS-CoV-2 infections were estimated by applying published age- and month-specific multipliers accounting for underdetection of reported COVID-19 case counts. Jurisdictions included Connecticut, Georgia, Massachusetts, Michigan, New Jersey, New York (excluding New York City), and Pennsylvania. Data analyses were conducted from August to December 2020. Race/ethnicity, sex, and age group (ie, ≤5, 6-10, 11-15, and 16-20 years). Overall and stratum-specific adjusted estimated MIS-C incidence per 1 000 000 person-months and per 1 000 000 SARS-CoV-2 infections. In the 7 jurisdictions examined, 248 persons with MIS-C were reported (median [interquartile range] age, 8 [4-13] years; 133 [53.6%] male; 96 persons [38.7%] were Hispanic or Latino; 75 persons [30.2%] were Black). The incidence of MIS-C per 1 000 000 person-months was 5.1 (95% CI, 4.5-5.8) persons. Compared with White persons, incidence per 1 000 000 person-months was higher among Black persons (adjusted incidence rate ratio [aIRR], 9.26 [95% CI, 6.15-13.93]), Hispanic or Latino persons (aIRR, 8.92 [95% CI, 6.00-13.26]), and Asian or Pacific Islander (aIRR, 2.94 [95% CI, 1.49-5.82]) persons. MIS-C incidence per 1 000 000 SARS-CoV-2 infections was 316 (95% CI, 278-357) persons and was higher among Black (aIRR, 5.62 [95% CI, 3.68-8.60]), Hispanic or Latino (aIRR, 4.26 [95% CI, 2.85-6.38]), and Asian or Pacific Islander persons (aIRR, 2.88 [95% CI, 1.42-5.83]) compared with White persons. For both analyses, incidence was highest among children aged 5 years or younger (4.9 [95% CI, 3.7-6.6] children per 1 000 000 person-months) and children aged 6 to 10 years (6.3 [95% CI, 4.8-8.3] children per 1 000 000 person-months). In this cohort study, MIS-C was a rare complication associated with SARS-CoV-2 infection. Estimates for population-based incidence and incidence among persons with infection were higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons. Further study is needed to understand variability by race/ethnicity and age group.
Identifiants
pubmed: 34110391
pii: 2780861
doi: 10.1001/jamanetworkopen.2021.16420
pmc: PMC8193431
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2116420Subventions
Organisme : NIDDK NIH HHS
ID : K23 DK119463
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Références
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Pediatr Infect Dis J. 2021 Apr 1;40(4):284-288
pubmed: 33264213
JAMA Pediatr. 2021 Apr 6;:
pubmed: 33821923
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):393-398
pubmed: 32463092
JAMA. 2020 Jul 21;324(3):294-296
pubmed: 32511676
Pediatrics. 2021 Mar;147(3):
pubmed: 33323493
Hosp Pediatr. 2020 Jun;10(6):537-540
pubmed: 32265235
Clin Infect Dis. 2020 Nov 25;:
pubmed: 33237993
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
BMJ. 2020 Jun 3;369:m2094
pubmed: 32493739
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
JAMA Netw Open. 2020 Nov 2;3(11):e2030280
pubmed: 33252688
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
N Engl J Med. 2020 Oct 29;383(18):1794-1795
pubmed: 33085854
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
J Pediatr. 2020 Aug 5;:
pubmed: 32768466
N Engl J Med. 2020 Jul 23;383(4):347-358
pubmed: 32598830
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1074-1080
pubmed: 32790663
Euro Surveill. 2020 Jun;25(22):
pubmed: 32524957